arrow
A

Aslam H. Anis

providence research
H指数:64
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biosimilar Policies and Their Impact on Market Penetration of Adalimumab, Etanercept and Infliximab: A Policy Synthesis and Descriptive Analysis in 13 OECD Countries

生物仿制药政策及其对阿达木单抗、依那西普和英夫利昔单抗市场渗透的影响: 13个经合组织国家的政策综合和描述性分析

2025-02-250
PRE
Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves

在Omicron变体波期间,基于人群的HIV感染者队列和匹配的非HIV感染者队列的冠状病毒疾病2019结果

AIDS
IF3.1
2024-07-110
OAAI
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study

HIV感染者突破性SARS-CoV-2感染的相关性: CIHR CTN 328研究的结果

2024-04-231
OAAI
Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada

加拿大HIV感染者接种冠状病毒疾病2019疫苗后的抗体中和能力

AIDS
IF3.1
2023-08-034
OAAI
SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)

与血清阴性对照相比,在接受抗逆转录病毒治疗的HIV感染者中,三剂疫苗诱导的T细胞反应SARS-CoV-2 (CTN 328 COVAXHIV研究)

2023-02-1911
OAAI
Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy

接受抑制性抗逆转录病毒治疗的HIV感染者接受三剂冠状病毒疾病2019疫苗接种后的抗体反应耐久性

AIDS
IF3.1
2022-12-2216
OAAI
COVID-19 vaccine immunogenicity in people with HIV

新型冠状病毒肺炎疫苗在HIV感染者中的免疫原性

AIDS
IF3.1
2022-11-1825
OAAI
Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV

在基于人群的HIV感染者队列中冠状病毒疾病2019疫苗的有效性

AIDS
IF3.1
2022-10-1917
OAAI
People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses

接受抑制性抗逆转录病毒治疗的人类免疫缺陷病毒在双重冠状病毒疾病2019疫苗接种和强烈的第三剂量反应后显示出典型的抗体持久性

2022-06-0735
OAAI
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

接受抑制性抗逆转录病毒治疗的HIV感染者对新型冠状病毒肺炎疫苗接种的体液免疫反应

2022-02-2865
OAAI